Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by whisky11on May 16, 2021 10:39pm
235 Views
Post# 33212296

RE:RE:big news is around the corner, they contacted big Pharma

RE:RE:big news is around the corner, they contacted big Pharma=PTBailey]
whisky11 wrote: If Pfizer or Johnson and Johnson get an observer to Laboratory in Australia, that will be big news.
It may come anytime.
News similar to that would help day traders,but if you're long on the stock, no news in my situation is good, it  give me time to buy more,(I'm waiting for Cash from a real estate deal )
Reverse split will create up movement in the stock price, why is that ? The reason  they want to do reverse split is because some  " specific "  investors demanded it,
So I presume if they do reverse split, some institutional investor will jump in. And this is big news they are talking about , it will offset stock price drop after split.
So if you go to my first sentence in this blog, what I'm saying is that this news or something similar, would show interest of big Pharma into
R- 107and then the stock price would go up and it create run on stock and reverse split won't be necessary at all.

 


Hey Whisky are you spectulating on the contact with big pharma or is there a link to that information? It would be big news

whisky11: I think there is some information about pharmaceuticals in the last letter, it's too late for me to copy and paste it but I will find out tomorrow. If I recall it right it is about contacting them and giving them information about R-107, also in the last letter there's about strategy what's next   for Claritas.
<< Previous
Bullboard Posts
Next >>